always looking for a good trade
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes. The company is waiting for orphan drug designation in feb13 or mar13
Will add shsreholder value. See what happenef with telk...was up 100÷
Regards
DARA are so close to break into a major movement up.
if you see the charts, the 3 most important MA averages are so close that after breaking those resistences will triger a major upper movement.
My opinion like yours...Anyone more agree...
Volume before the price...2 days ago we had that...
Quiet before the Storm.
Nice to add, Already have 20k.
Agree...is someone shorting this stock...
All buys from the insiders lately and i believe a good answer to the CRL.
Something is not quiet clear here....
This is not normal.
If
At least this last couple of down days has a good thing:
In case of approaval it isn't price in like it happen with others (ex:alxa).
So if that were the case plenty of room to go up.
If not will be also a good buy after news. Another CRL will put the company even more close to approaval.
It is important to note that in the previous CRL no more studies were requeired.
Regards
Hellking could you send me your email via PM. Thanks
I will place my sell order at $5.5
Thats my bet...lets see what will happen. To change a litle bear sentiment around this company.
But i have to agree with you...with FDA decisions what we can do is bet.
Without having an ADCOM meeting it is hard to understand what is the FDA opinion.
Even after a CRL received it is dificult to say if the company was able to answer to all points. How many companies have received a CRL and the drug wasn't ok at 2 time....a few...
I have a small position here and will wait FDA decision .
Good luck to all....with this low float everthing is possible.
I am building a stronger position in RPTP and DARA.
Thank and Regards.
This two trading days has been interesting to watch.
Something is going on.DARA have volume above the averages.
And more interesting is that averages are all close here.
Lets see wath will happen. I want ti buikd a nice position in here.
Tomorrow i have plans to buy more.
Regards
DARA is a good investment and breaking out.
Nice article
We will find out soon...
This was the bigger volume day in 3 months and without any news...
Strange but seems very positive.
Nice. one more thing: breakout
My opinion is that DARA started today the breakout.
You could see that in finviz or draw yourself a trend line. And this also above the 50MA.
My opinion again. A strong movement up is eminent.
Regards
Today the most important:Volume.
Seems this is about to run up.
They have money.Plus products in the market and others ready to be launched.
And most important for short term:pending orphan designation
you have a nice position
Increasing mine to.
Add a few more shares.
Volume today is well above the average
Volume beforw the price...
With orphan designation this will go much higher.
Join that plus good sales and will have $2
Some profit taking now...this should move higher at the end of the day
Agree.
Plenty of room to go up.
Just the start.
TELK(UP 105%) vs DARA (UP ?%)
Telik Announces Orphan Designation Of Telintra® For Treatment Of Myelodysplastic Syndrome and up 105%
Dara are waiting for Orphan Designation....if ok how much DARA will be up...?
Regards
agree. start position today.
Add a few more. Average PT of $9.
Nice to see green in after hours.
Excellent move today...above $6 and moving to $7
RPTP is holding well above $5.
All the DD was made in this board all ready. I believe it is a good investement for 2013.
With FDA and EMEA aproaval RPTP could doble todays price.
Agree. Share the same opinion about path
PATH 3.44 Possible Breakout:
At only 2/3 weeks from the PDUFA PATH is moving sideways. Charts may not be very important for now, but in my opinion a breakout is possible very soon.
This has the 3,50 level and the 200MA (3,52) as resistence, after that this could move higher...( fill the gap at 4,4 first...?)
Will be interesting the next couple of days.
Best Reagards
About PATH
What is interesting to note is that market is not (so far) pricing in the possible value after approaval as we saw with alxa and NPSP.
I think it will be very very interesting the next 2/3 weeks.
Regards
Agree. This creates a an excellente buying opportunity.
Bought today a few more at lower prices and preparing to add more.
Very interesting company at near tearm, of course we could see some short term weakness.
Raptor Pharma shares should be bought on any weakness, says JMP Securities
in, http://finance.yahoo.com/news/raptor-pharma-shares-bought-weakness-122856459.html
Oppenheimer Says Raptor Pharma (RPTP) Procysbi Delay Immaterial, Reiterates Buy
Oppenheimer has an Outperform rating on Raptor Pharmaceuticals (NASDAQ: RPTP) with a price target of $11.00.
in, http://www.streetinsider.com/Analyst+Comments/Oppenheimer+Says+Raptor+Pharma+(RPTP)+Procysbi+Delay+Immaterial,+Reiterates+Buy/7969012.html
From my DD: $5.5 to $7.
We shall see.
They have money and orphan status. 3 months doesn't representa major problem
what have change is that now myself and other investors will have the opportunity to bUY shares at better prices and hold a Litle more.
Agree,but I will add more 3000 this year
And wait a litle more.
Very nice chances of aproaval in eua and in europe. Almost at same time
best regards
Agree, I now have PATH and RPTP.
Both, seems good in near term future
Regards
Hi
I saw your PM.
Send me your e-mail and i will answer you.
Hi
About PATh and RPTP, do you think it is soon to re enter in that stocks? Or should we wait for January
Best Regards
Since March i had plenty of time to buy them cheap.
Best Regards and Good Investments
Jindal, Militaryman1 and i, both have 70Million shares holding strong and long.
We both believe in TGGI management in order to improve shareholder value.
And they are doing that so far, as you can read in the PR.
Best Regards